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Abstract
Lipocalins (LCNs) are members of a family of evolutionarily conserved genes present in all kingdoms of life. There are
19 LCN-like genes in the human genome, and 45 Lcn-like genes in the mouse genome, which include 22 major urinary
protein (Mup) genes. The Mup genes, plus 29 of 30 Mup-ps pseudogenes, are all located together on chromosome
(Chr) 4; evidence points to an “evolutionary bloom” that resulted in this Mup cluster in mouse, syntenic to the human
Chr 9q32 locus at which a single MUPP pseudogene is located. LCNs play important roles in physiological processes by
binding and transporting small hydrophobic molecules —such as steroid hormones, odorants, retinoids, and lipids—in
plasma and other body fluids. LCNs are extensively used in clinical practice as biochemical markers. LCN-like proteins
(18–40 kDa) have the characteristic eight β-strands creating a barrel structure that houses the binding-site; LCNs are
synthesized in the liver as well as various secretory tissues. In rodents, MUPs are involved in communication of
information in urine-derived scent marks, serving as signatures of individual identity, or as kairomones (to elicit fear
behavior). MUPs also participate in regulation of glucose and lipid metabolism via a mechanism not well understood.
Although much has been learned about LCNs and MUPs in recent years, more research is necessary to allow better
understanding of their physiological functions, as well as their involvement in clinical disorders.

Introduction
Lipocalins (LCNs) are members of a family that includes a
diverse group of low-molecular-weight (18–40 kDa) proteins. The larger members of this family undergo cleavage
to form the ultimate LCN protein. Comprising usually
150–180 amino-acid residues, these proteins belong to the
calycin superfamily and are widely dispersed throughout
all kingdoms of life [1]. LCNs are evolutionarily conserved
and share an eight-stranded antiparallel β-sheet structure;
this forms a “barrel” which is the internal ligand-binding
site that interacts with and transports small hydrophobic
molecules—such as steroid hormones, odorants (e.g.,
pheromones), retinoids, and lipids [2, 3].
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There are three main structurally conserved regions
(SCR1, SCR2, SCR3) that are shared in the lipocalin fold;
these represent a moiety composed of three loops that are
close to each other in the three-dimensional structure of
the β-strands that make up the barrel [4–7]. Based on the
SRCs, two separate groups have been proposed: the kernel
LCNs and the outlier LCNs [3]. The kernel LCNs represent a core set of proteins sharing the three characteristic
motifs, while the outlier LCNs, which are more divergent
family members, typically share only one or two motifs
[4]. Based on this categorization—retinoic acid-binding
protein-4 (RBP4), α1-microglobulin (A1M), apolipoprotein
D (APOD), complement C8 gamma chain (C8G), prostaglandin D2 synthase (PTGDS), and the major urinary proteins (MUPs)—have all been classified as kernel lipocalins,
while odorant-binding proteins (OBP2A, OBP2B) and von
Ebner’s gland protein (LCN1) are included in the outlier
category [4, 7].
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Depending on the structure of the individual LCN, the
binding-site pocket can accommodate molecules of various sizes and shapes—thus contributing to the diversity
of functions within this protein family [5]. Lipocalin
crystal structures confirm the highly conserved eight
continuously-hydrogen-bonded antiparallel β-strand domains creating the barrel.
The fatty acid-binding protein (FABP) gene family is
considered a related, but distinct, subfamily of the
calycin superfamily [8] and will not be discussed further here. Another subset of the lipocalins worthy of
mention is the immunocalin subfamily. These include
α1-acid glycoprotein, α1-microglobulin/bikunin precursor, and glycodelin, each of which exert significant
immunomodulatory effects in cell culture [9, 10];
interestingly, all three are encoded by genes in the human Chr 9q32-34 region—together with at least four
other lipocalins (neutrophil gelatinase-associated lipocalin, complement factor γ-subunit, tear prealbumin,
and prostaglandin D synthase), which also might exert
anti-inflammatory and/or antimicrobial activity [11].

Lipocalin family in humans
Among bacteria, plants, fungi, and animals, more than
1000 LCN genes have been identified to date. Nineteen
LCN genes, encoding functional LCN proteins, exist in the
human genome (Table 1). Figure 1 dendrogram shows the
evolutionary relatedness of these human LCN proteins.
In humans, LCNs are located in blood plasma and
other body fluids such as tears and genital secretions,
in which they serve as carriers for a variety of small
molecules [5]. LCNs also can play important roles in
disease such as diabetic retinopathy [12], and, as a result, they are extensively used clinically as biochemical
markers. For example, A1M (α1-microglobulin/bikunin precursor, encoded by the AMBP gene) is a biomarker of proteinuria and indicator of declining renal
function [13].
Lipocalin-1 (LCN1; human tear pre-albumin, or von
Ebner’s gland protein) is one of four major proteins in
human tears, acting as a lipid sponge on the ocular surface [14, 15]. LCN1 is produced by lacrimal glands and
secreted into tear fluid. Decreased LCN1 levels are associated with Sjögren’s disease, LASIK-induced dry-eye
disease [16], and diabetic retinopathy [12].
Lipocalin-2 (LCN2; also known as neutrophil gelatinaseassociated lipocalin) mediates various inflammatory processes by suppressing macrophage interleukin-10 (IL10)
production [17, 18]. Several studies have shown that
LCN2 gene expression in adipose tissue is elevated in
insulin-resistant states [19, 20]. LCN2 is also involved in
kidney development and used as a biomarker for acute
and chronic renal injury [21].
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Odorant-binding proteins 2A and 2B (encoded by the
OBP2A and OBP2B genes) are members of the LCN family.
OBP2A is highly expressed in the oral sphere (e.g., nasal
mucus, salivary, and lacrimal glands), whereas OBP2B is
expressed in endocrine organs (e.g., mammary gland and
prostate) [22]. Functioning as soluble-carrier proteins,
OBP2A and OBP2B can bind reversibly to odorants [23].
The AMBP gene encodes α1-microglobulin/bikunin
precursor protein; α1-MG (A1M) is the lipocalin—derived from proteolytic cleavage of AMBP [24]. A1M is
secreted into plasma, where it can exist free, or bound,
to immunoglobulin-A or albumin. Although the molecular weight of A1M is 27.0 kDa, it is freely filtered
through the glomerulus and reabsorbed by proximal
tubular cells [25]; for this reason, A1M is a biomarker
of proteinuria, i.e., increased levels in urine indicate a
defect in proximal tubules. A1M is considered to be a
major factor for progressive impairment of renal function, as well as for early diagnosis of acute allograft rejection [13, 24, 26]. Recent studies have shown A1M to
be expressed in rat retinal explants and to have oxygen
radical-scavenging and reductase properties; these findings suggest that A1M might protect against oxidative
stress and possibly be involved in the response to retinal detachment [27, 28].
Other members of the LCN family include apolipoproteins D (APOD) and M (APOM)—which interestingly exhibit structural similarities to LCNs rather than to other
apolipoproteins. APOD is an atypical apolipoprotein, because it is highly expressed in mammalian tissues such as
liver, kidney, and central nervous system. APOD is a
component of HDL cholesterol. Recent studies have
shown that abnormal APOD expression is associated
with altered lipid metabolism; three distinct missense
mutations (Phe36Val, Tyr108Cys, and Thr158Lys) in
African populations link APOD with metabolic syndrome
[29]. A recent study showed that APOM, which resides in
the plasma HDL fraction, acts as a chaperone for sphingosine-1-phosphate (S1P) and facilitates interaction between
S1P and plasma HDL, thereby exhibiting a vasculoprotective effect [30].
The protein encoded by the complement C8 gamma
chain gene (C8G) is one of the three subunits present in
complement component 8 (C8). It is an oligomeric protein
composed of three non-identical sub-units (α, 64-kDa; β,
64-kDa; γ, 22-kDa); the gamma chain is the only one that
belongs to the lipocalin family [31]. C8 is part of the
membrane-attack complex (MAC) that participates in
irreversible association of the complement proteins
C5b, C6, C7, and C9 to form a cytolytic complex that
inserts into, and directly lyses, microbes [32]. Activation of complement triggers the assembly of MAC,
which is then deployed to kill a wide range of
Gram-negative bacteria [33]. Two functionally distinct
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Table 1 List of all human LCN and mouse Lcn genes—with official gene symbols, full protein name, aliases, chromosomal locations,
isoforms, National Center for Biotechnology Information (NCBI) RefSeq mRNA accession numbers, NCBI RefSeq protein accession
numbers, and total number of amino acids (# of AAs) [information retrieved and confirmed from https://www.genenames.org/needs
a close bracket]
Gene
Full protein
symbol name
LCN1

Aliases

Chromosome

TP; TLC; PMFA; VEGP

9q34

NM_001252617.1 NP_001239546

Lipocalin-1 isoform
2 precursor

9q34

NM_001252618.1 NP_001239547.1 233

Lipocalin-1 isoform
3 precursor

9q34

NM_001252619.1 NP_001239548.1 230

Lipocalin-1 isoform
1 precursor

Isoforms

Ref seq mRNA
number

Ref seq protein
number

No. of
AAs
176

LCN2

Lipocalin-2

24p3; MSFI; NGAL

9q34

NM_005564.3

NP_005555.2

198

Lcn2

Lipocalin-2

NRL; 24p3; Sip24;
AW212229

2

NM_008491.1

NP_032517.1

200

Lcn3

Lipocalin-3

Vnsp1

2

NM_010694.1

NP_034824.1187 187

Lcn4

Lipocalin-4

Vnsp2; A630045M08Rik

2

NM_010695.1

NP_034825.1

Lcn5

Lipocalin-5

Erabp; MEP10; ERABP

2

185

Epididymal-specific
XM_006497665.1 XP_006497728.1 208
lipocalin-5 isoform X1
Epididymal-specific
XM_006497666.3 XP_006497729.1 202
lipocalin-5 isoform X2
Epididymal-specific
XM_006497667.2 XP_006497730.1 190
lipocalin-5 isoform X3
Epididymal-specific
XM_006497668.2 XP_006497731.1 190
lipocalin-5 isoform X4
Epididymal-specific
XM_006497669.1 XP_006497732.1 173
lipocalin-5 isoform X5

LCN6

Lipocalin-6

LCN5; hLcn5; UNQ643

9q34.3

Lcn6

Lipocalin-6

9230101D24Rik

2

NM_198946.2

NP_945184.1

163

Epididymal-specific
lipocalin-6 isoform
1 precursor;

NM_001276448.1 NP_001263377.1 245

Epididymal-specific
lipocalin-6 isoform
2 precursor

NM_177840.4

NP_808508.2

181

LCN8

Lipocalin-8

EP17; LCN5

9q34.3

NM_178469.3

NP_848564.2

152

Lcn8

Lipocalin-8

EP17; Lcn5; mEP17;
9230106L18Rik

2

NM_033145.1

NP_149157.1

175

LCN9

Lipocalin-9

HEL129; 9230102I19Rik

9q34.3

NM_001001676.1 NP_001001676.1 176

Lcn9

Lipocalin-9

9230102I19Rik

2

NM_029959.2

LCN10

Lipocalin-10

9q34.3

NM_001001712.2 NP_001001712.2 200

Lcn10

Lipocalin-10

9230112J07Rik

2

NM_178036.4

Lcn11

Lipocalin-11

Gm109

2

NM_001100455.2 NP_001093925.1 178

LCN12

Lipocalin-12

9q34.3

NM_178536.3

NP_848631.2

192

Lcn12

Lipocalin-12

9230102M18Rik

2

NM_029958.1

NP_084234.1

193

LCN15

Lipocalin-15

PRO6093; UNQ2541

9q34.3

NM_203347.1

NP_976222.1

184

Lcn15

Lipocalin-15

Gm33749

2 A3; 2

XM_006498514.1 XP_006498577.1 202

Lcn16

Lipocalin-16

Gm39773

2

XM_011239226.1 XP_011237528.1 181

Lcn17

Lipocalin-17

Gm39774

2

XM_011239227.1 XP_011237529.1 193

OBP2A

Odorant binding
protein 2A

OBP; LCN13; OBP2C; OBPIIa; 9q34
hOBPIIa

NM_001293189.1 NP_001280118.1 228

Obp2a

Odorant binding
protein 2A

Lcn13; BC027556

2

NM_153558.1

OBP2B

Odorant-binding

LCN14; OBPIIb

9q34

NM_001288987.1 NP_001275916.1 170

NP_084235.1

NP_828875.1

NP_705786.1

178

182

176
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Table 1 List of all human LCN and mouse Lcn genes—with official gene symbols, full protein name, aliases, chromosomal locations,
isoforms, National Center for Biotechnology Information (NCBI) RefSeq mRNA accession numbers, NCBI RefSeq protein accession
numbers, and total number of amino acids (# of AAs) [information retrieved and confirmed from https://www.genenames.org/needs
a close bracket] (Continued)
Gene
Full protein
symbol name

Aliases

Chromosome

Isoforms

Ref seq mRNA
number

Ref seq protein
number

No. of
AAs

protein-2B
Obp2b

Odorant-binding
protein-2B

Lcn14

2

NM_001099301.1 NP_001092771.1 176

AMBP

Alpha-1-microglobulin/
bikunin precursor

A1M; HCP; ITI; UTI; EDC1;
HI30; ITIL; IATIL; ITILC

9q32-q33

NM_001633.3

NP_001624.1

352

Ambp

Alpha 1 microglobulin/
bikunin precursor

AI194774, ASPI, HI-30,
Intin4, Itil, UTI

4 B3; 4
33.96 cM

NM_007443.4

NP_031469.1

349

APOD

Apolipoprotein D

3q29

NM_001647.3

NP_001638.1

189

Apod

Apolipoprotein D

16 B2; 16
21.41 cM

NM_001301353.1 NP_001288282.1 189

APOM

Apolipoprotein M

G3a; NG20; apo-M;
HSPC336

6p21

NM_019101.2

NP_061974.2

188

Apom

Apolipoprotein M

G3a; NG20;
1190010O19Rik

17; 17 B1

NM_018816.1

NP_061286.1

190

C8G

Complement component
8, gamma polypeptide

C8C

9q34.3

NM_000606.2

NP_000597.2

202

C8g

Complement component
8, gamma polypeptide

2 A3; 2
17.31 cM

NM_001271777.1 NP_001258706.1 168

ORM1

Orosomucoid-1

ORM; AGP1; AGP-A;
HEL-S-153w

9q32

NM_000607.2

NP_000598.2

201

Orm1

Orosomucoid-1

Agp-1; Agp-2; Orm-1

4 B3; 4
33.96 cM

NM_008768.2

NP_032794.1

207

ORM2

Orosomucoid-2

AGP2; AGP-B; AGP-B

9q32

NM_000608.2

NP_000599.1

201

Orm2

Orosomucoid-2

Agp1; Orm-2

4 B3; 4
33.96 cM

NM_011016.2

NP_035146.1

207

PAEP

Progestagen-associated
endometrial protein

GD; GdA; GdF; GdS; PEP;
PAEG; PP14

9q34

NM_001018049.1 NP_001018059.1 180

PTGDS

Prostaglandin D2 synthase; PDS; PGD2; PGDS; LPGDS;
21 kDa (brain)
PGDS2; L-PGDS

9q34.2-q34.3

NM_000954.5

NP_000945

190

Ptgds

Prostaglandin D2 synthase; PGD2; PGDS; 21 kDa;
21 kDa (brain)
PGDS2; Ptgs3; L-PGDS

2 A3; 2
17.28 cM

NM_008963.3

NP_032989.2

189

RBP4

Retinol-binding protein-4,
plasma

RDCCAS; MCOPCB10

10q23.33

NM_006744.3

NP_006735.2

201

Rbp4

Retinol-binding protein-4,
plasma

Rbp-4

19 C2; 19
32.75 cM

NM_001159487.1 NP_001152959.1 245

C8-deficiency states have been identified: the first reflects
a lack of the alpha and gamma chains and has been reported in Afro-Caribbean, Hispanic, and Japanese populations; the second results from lack of the beta chain and is
found mainly in Caucasians [34, 35]. Deficiency of C8
complement is a very rare primary immunodeficiency associated with invasive and recurrent infections by Neisseria
meningitidis [32, 36, 37].
Orosomucoids (ORM1 and ORM2), α1-acid glycoproteins (trivial name AGPs), belong to the subfamily of
immunocalins. ORM1 is an acute phase protein secreted
by hepatocytes in response to inflammation, with its expression being regulated by pro-inflammatory cytokines

such as IL1 and IL6, the chemokine IL8, and glucocorticoids [38]. ORM1 and ORM2 are polymorphic proteins—
commonly referred to as ORM/AGP with four variants in
humans: AGP F1; AGP F2; AGP S, encoded by the ORM1
gene; and AGP A, encoded by the ORM2 gene [39]. AGPs
are important members of the lipocalin family, because
their capacity to bind to basic drugs can affect plasma free
drug concentrations, playing a key role in a drug’s volume
of distribution, metabolism, and therapeutic effect [40].
The ORM1 and ORM2 proteins have been recently identified as predictive urinary biomarkers for rheumatoid arthritis [41]. In addition, they are predictive markers for
systemic lupus [42] and chronic inflammation [43].
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Plasma retinol-binding protein 4 (RBP4) is a 21-kDa
transporter of all-trans-retinol and belongs to the lipocalin family [56, 57]. RBP4 circulates in plasma as a moderately tight 1:1 M complex with vitamin A. RBP4 is
secreted mainly by hepatocytes and also by adipose tissue [58]. In humans, increased circulating RBP4 levels
have been correlated with obesity [59], insulin resistance,
and type-2 diabetes [60, 61]. Insulin resistance has been
long considered to play a key role in the development of
non-alcoholic fatty liver disease (NAFLD) [62]—which is
associated with altered RBP4 levels. Information in the
literature on this association, however, is controversial.
Several studies have reported significantly increased
RBP4 levels in patients with NAFLD [63–66], whereas
other studies have shown no difference on RBP4 levels
between control and NAFLD groups [67, 68].
There is limited information in the literature regarding
human LCN6, LCN8, LCN9, LCN10, LCN12, or LCN15.

Fig. 1 Dendrogram of lipocalins (LCNs) in the human genome.
Although the names listed are the official human gene symbols
[https://www.genenames.org/], this dendrogram is based on the
alignment of proteins (listed in Table 1), using multiple sequence
alignment by CLUSTALW (http://www.genome.jp/tools/clustalw/)

The progestagen-associated endometrial protein (PAEP)
is a secreted immunosuppressive glycoprotein (28 kDa),
also termed glycodelin, i.e., one of the immunocalins. Studies have shown that PAEP downregulation can lead to abortion during the first trimester—due to increased activation
of the immune system [44, 45]. In addition, PAEP has been
found expressed in many tumors (e.g., gynecological malignancies, lung cancer, and melanoma) [46–48].
The protein encoded by the prostaglandin D2 synthase
(PTGDS) gene is a glutathione-independent prostaglandin
synthase (PTGDS). PTGDS is involved in the arachidonic
acid cascade, converting prostaglandin H2 to prostaglandin D2 (PGD2), and is preferentially expressed in brain
[49]. Increased PTGDS expression has been shown in patients having attention deficit hyperactivity disorder, compared with patients having bipolar disorder [50]. Another
study suggests that dysregulated PTGDS mRNA expression is associated with rapid-cycling bipolar depression
[49]. Enhanced PTGDS expression has also been associated with various malignancies [51–55].

Lipocalin family in mice
Lipocalins have been extensively studied in the mouse.
Forty-five proteins belong to this family in mice
(Table 1), which also includes major urinary proteins
(MUPs) as members of this family (Fig. 2). All of the
LCN genes are expressed in both humans and mice
(Table 1), with the only exception of LCN1, which is
found only in human—whereas Lcn3, Lcn4, Lcn5, Lcn11,
Lcn16, Lcn17, and all the functional Mup genes are
found in mouse but not human.
MUPs are intriguing small proteins (19–21 kDa) found
in mouse urine; in rats, MUPs are known as α2u-globulins
[69–72]. (For the purpose of this review, MUPs will refer
to major urinary proteins in both mouse and rat.) While
the presence of proteinuria is considered in humans to be
a pathological renal condition, this is not the case for mice
or rats [70]. Under physiological conditions, rodents excrete substantial levels of protein in urine, with MUPs accounting for > 90% of total protein content [70, 73, 74],
playing a key role in chemo-signaling between animals to
coordinate social behavior [75]. MUPs represent highly
homologous proteoforms that control the release of volatile pheromones for urinary scent marks by transporting
them into the vomeronasal organ (VNO) [76, 77]. MUPs
bind pheromones within the hydrophobic calyx of the
protein structure where hydrophobic binding sites exist
for small lipophilic ligands. The affinity of each MUP for
specific ligands varies, according to its subtype [70, 78],
and depends on the amino-acid sequence in the binding
domain [79, 80]. MUP affinity is most affected by polymorphisms that influence amino acids on the luminal surface of the ligand-binding domain (pocket)—rather than
on the protein surface where most sequence differences
are observed [73]. In addition, MUPs may act as direct
stimulants of pheromone receptors [81].
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secretory tissues—such as nasal tissue, mammary, salivary, submaxillary, and lacrimal glands [87, 88]—as well
as skeletal muscle, kidney, brain, spleen, heart, epididymal adipocytes, and brown adipose tissue [89–91].
MUP synthesis is initiated in response to different hormonal signals during various developmental stages; for
example, liver synthesis of MUPs begins at onset of puberty and on through adulthood [92], whereas MUP
synthesis in lacrimal gland starts 1 to 2 weeks before
onset of puberty and continues into adulthood [83]. In
addition, the specific Mup mRNA subtype produced
varies from tissue to tissue [93] (Table 2).

Fig. 2 Dendrogram of mouse Lcn and Mup proteins. Although the
names listed are the official mouse gene symbols [http://
www.informatics.jax.org/], this dendrogram is based on the
alignment of proteins (listed in Tables 1 and 2), using multiple
sequence alignment by CLUSTALW (http://www.genome.jp/tools/
clustalw/)

MUPs are primarily synthesized in post-pubescent
mouse liver in response to various hormones such as testosterone, growth hormone, thyroxine, insulin, and glucocorticoids [82, 83]. MUP synthesis is sex-dependent—
resulting in (three- to fourfold) higher protein concentrations in post-pubescent males than female mice [84].
MUP expression is stimulated by androgens and leads
to higher expression levels in adult males than in females, as well as immature males [70, 85]. Because their
expression is stimulated by androgens, MUP synthesis
is gender-dependent with higher (three- to fourfold)
protein levels occurring in adult males than in females
or immature males [70, 85]. For example, in C57/BL6
mice, MUPs represent 3.5–4% of total protein synthesized in male liver, but only 0.6–0.9% in female liver
[86]. Mup mRNA is also expressed in a number of

The MUP gene cluster in mouse and human
genomes
Interestingly, the mouse Mup gene cluster (22 protein-coding genes; Table 3) can be divided into two subgroups. The
first group (Mup3, Mup4, Mup5, Mup6, Mup20, and
Mup21) is slightly older (Fig. 2) and contains a more divergent class of genes. The second group comprises the
remaining 16 Mup genes, which share almost 99% sequence identity [75, 94]. The predicted gene, previously
designated Gm21320 (“gene model 21320”), has now been
renamed Mup22, cf. [http://www.informatics.jax.org/].
As members of the LCN family, MUPs exhibit conservation in the common three-dimensional structure
of the protein family, i.e., a central area pocket formed
by eight hydrophobic β-strand domains that form a barrel (Fig. 3) [81, 95]. This structure enables the MUPs to
serve as carrier proteins for small lipophilic molecules
such as pheromones and other chemical signals [78,
81]. All 22 mouse Mup protein-coding genes are located in a cluster (the Mup locus) on Chr 4 (Fig. 4 a, b)
[96]. There are also 29 Mup-ps pseudogenes in the Chr
4 Mup cluster (intriguingly, the one remaining pseudogene, Mup-ps22, is located on Chr 11).
An “evolutionary bloom” is defined when one sees a recent, phylogenetically independent proliferation of close
paralogs or lineage-specific gene family expansion [97].
Examples of this phenomenon have been extensively studied in the large and diverse cytochrome P450 superfamily
[97]. For example, the koala’s ability to detoxify eucalyptus
Table 2 Mouse tissues known to express Mup mRNA [93]
Mup mRNA

Tissue

Mup1

Liver

Mup2

Mammary gland, liver

Mup3

Liver

Mup4

Parotid gland, lacrimal gland,
nasal expression

Mup5

Submandibular gland, sublingual gland,
lacrimal gland

Mup6

Parotid gland
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Table 3 List of all mouse Mup genes [http://www.informatics.jax.org/], with official gene symbols, aliases, chromosomal locations, isoforms,
National Center for Biotechnology Information (NCBI) RefSeq mRNA accession numbers, NCBI RefSeq protein accession numbers, and total
number of amino acids (# of AAs) [information retrieved and confirmed from https://www.ncbi.nlm.nih.gov/genome.]
Gene
Aliases
symbol

Chromosome

Isoforms Ref seq mRNA
number

Ref seq protein
number

Full protein
name

No. of AAs

Mup1

Major urinary Mup7; Up-1; Ltn-1; Mup-1;
protein-1
Mup-a; Mup10; Lvtn-1

4

MUP 1 isoform
b precursor

NM_001163010.1 NP_001156482.1 121

Mup2

Major urinary Mup4; Mup-2; AA589603
protein-2

4

MUP 2 isoform
1 precursor

NM_001045550.2 NP_001039015.1 180

4

MUP 2 isoform 2

NM_001286096.1 NP_001273025.1 119

4

MUP 2 isoform
1 precursor

NM_008647.4

NP_032673.3

180

Mup3

Major urinary MUP15; Mup-3;
protein-3
Mup25; MUPIII

4

MUP 3 precursor

NM_001039544.1 NP_001034633.1 184

Mup4

Major urinary Mup1; Mup-4
protein-4

4

MUP 4 precursor

NM_008648.1

NP_032674.1

178

Mup5

Major urinary Mup18
protein-5

4

MUP 5 precursor

NM_008649.2

NP_032675.2

180

Mup6

Major urinary Mup2; Gm12544;
protein-6
OTTMUSG00000007423

4

MUP (Mup)-like
precursor

NM_001081285.1 NP_001074754.1 179

Mup7

Major urinary Mup3; Gm12546;
protein-7
OTTMUSG00000007428

4

MUP 7 precursor

NM_001134675.1 NP_001128147.1 235

Mup8

Major urinary Mup5; Gm12809;
protein-8
OTTMUSG00000008509

4

MUP 8 precursor

NM_001134676.1 NP_001128148.1 235

Mup9

Major urinary Mup2; Mup6; Gm14076;
protein-9
OTTMUSG00000015595

4

MUP 2-like precursor NM_001281979.1 NP_001268908.1 180

Mup10

Major urinary Mup8; 2610016E04Rik
protein-10

4

MUP 10 precursor

NM_001122647.1 NP_001116119.1 180

Mup11

Major urinary Gm12549;
protein-11
OTTMUSG00000007431

4

MUP 11 precursor

NM_001164526.1 NP_001157998.1 181

Mup12

Major urinary Gm2024
protein-12

4

MUP 12 precursor

NM_001199995.1 NP_001186924.1 180

Mup13

Major urinary Mup11; Gm13513;
protein-13
OTTMUSG00000012492

4

MUP 13 precursor

NM_001134674.1 NP_001128146.1 235

Mup14

Major urinary Mup12; Gm13514;
protein-14
OTTMUSG00000012493

4

MUP 14 precursor

NM_001199999.1 NP_001186928.1 180

Mup15

Major urinary Mup13; Gm2068
protein-15

4

MUP 15 precursor

NM_001200004.1 NP_001186933.1 180

Mup16

Major urinary
protein-16

4

MUP 16 precursor

NM_001199936.1 NP_001186865.1 180

Mup17

Major urinary MUP 17; Gm12557;
protein-17
OTTMUSG00000007480

4

MUP 17 precursor

NM_001200006.1 NP_001186935.1 180

Mup18

Major urinary Mup6
protein-18

4

MUP 6 precursor

NM_001199333.1 NP_001186262.1 181

Mup19

Major urinary Mup8; Mup11; Mup14; Mup17; Gm12552; 4
protein-19
100039247; OTTMUSG00000007472

MUP 11 and 8
precursor

NM_001135127.2 NP_001128599.1 180

Mup20

Major urinary Mup24; darcin; Gm12560;
protein-20
OTTMUSG00000007485

4

MUP 20 precursor

NM_001012323.1 NP_001012323.1 181

Mup21

Major urinary Mup; Mup26; Gm11208; bM64F17.1;
protein-21
bM64F17.4; OTTMUSG00000000231

4

MUP 26 precursor

NM_001009550.2 NP_001009550.1 181

Mup22

Major urinary Gm21320
protein-22

4

MUP 2-like isoform
X1

XM_003688783.3 XP_003688831.1 181

Charkoftaki et al. Human Genomics

(2019) 13:11

Fig. 3 Structure of prototypical mouse urinary protein. The crystal
structure consists of eight β-strands, forming a calyx-shaped barrel
(red); this encloses an internal ligand-binding site. There are also an
α-helix (green) and four 310-helices (blue); the hydrophobic pocket is
located inside the barrel. AB, BC, CD, DE, EF, FG, GH, HI, AND βI
denote the amino-acid segments between the β-strands (This
diagram taken from Ref. [95])

leaves appears to be due to an evolutionary bloom within
a cytochrome P450 gene group; the koala’s CYP2C subfamily was found to comprise 31 putative protein-coding
functional enzymes, compared to 15 Cyp2c genes in
mouse and just four CYP2C genes in human [98]. Another
example is the mouse Scgb gene superfamily—which
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includes a number of encoded androgen-binding proteins
involved in mate selection [99]; this is fascinating, because
the Mup cluster (described herein) also encodes proteins
involved in mate selection. It has been suggested that
these evolutionary blooms might represent simply a stochastic process [97]. However, it is more likely these
blooms are the result of environmental pressures
needed for the organism to survive (i.e., find food, avoid
predators, and reproduce) at a particular moment in
evolutionary time.
Mup gene polymorphisms in rat and mouse have
shown significant differences. Yet, such differences have
not been seen in genomes of other mammalian species
for which whole-genome sequences have been explored
[75]. Although the amino acid sequence of MUP homologs between rat and mouse is ~ 65%, there is a characteristic six amino-acid consensus sequence (Glu-GluAla-Ser-Ser-Thr) that remains highly conserved between these two species [100]. In general, species differences in MUP proteins appear to be mainly due to
glycosylated MUP amino-acid residues that occur in
rats, but not mice [100]. Most other mammalian species
(e.g., dog, baboon, gorilla, and chimpanzee) have only one
functional protein-coding MUP gene, except for horse
that has three functional MUP genes [75].
The human MUP-related gene is a pseudogene
(MUPP, located at Chr 9q32). Using the UCSC genome
browser [https://genome.ucsc.edu/], one can visualize
that human Chr 9q32 is syntenic to mouse Chr 4 at
60,498,012 Mb to 60,501,960 Mb, where the Mup cluster of 22 Mup genes is located; in fact, the human
ZFP37 and mouse Zfp37 gene flank the “MUP region”
in both human and mouse, respectively. The human

A

B

Fig. 4 Chromosomal location of mouse Mup genes and pseudogenes. a The Mup cluster region, located at 60,498,012 Mb to 60,501,960 Mb (red
vertical rectangle). Taken from the Ensembl genome browser. b The Chr 4 region (in greater detail)—showing ten of the 22 Mup genes (Gm21320
is Mup22) in the Mup cluster and 12 of the 29 Mup-ps pseudogenes
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MUPP locus exhibits a high degree of sequence similarity to mouse Mup functional genes but contains
coding-sequence disruptions that prevent the gene
product from being formed [101]. The human MUPP
shows a G > A transition (relative to the chimpanzee
MUP sequence) that disrupts a splice-donor site [75];
this is interesting because this G > A mutation has not
been observed in mammals other than humans [101].
The human MUPP pseudogene sequence is most similar to the mouse Mup-ps4 pseudogene [75].
One of the main functions of MUP proteins is to promote aggressive behavior through binding to vomeronasal
pheromone receptors (V2Rs) in the accessory olfactory
neural pathway. Even though there is a co-expansion of
MUPs and V2Rs in mouse, rat, and opossum—all human
V2R receptors have become inactive, possibly leading to
the pseudogenization of the single human MUP gene [102,
103]. In other words, the absence of the specific V2R removed the selection pressure for a functional MUP ligand.

Parallel expansions of Mup clusters
The last common ancestor of rat and mouse had either
a single, or a small number of, Mup genes [75]. By determining the extent of Mup gene expansions across
non-rodent lineages, Logan and colleagues were able to
identify orthologs of the Slc46a2 and Zfp37 genes (and
the contiguous genomic sequence spanning the interval
between these two genes) in nine additional placental
mammals [75]. Whereas C57BL/6J mice have a cluster
of 22 distinct Mup genes on Chr 4 and rats have nine
distinct Mup genes, mammalian species such as dog,
pig, baboon, chimpanzee, bush baby, and orangutan—
each has a single Mup gene (with no evidence of additional pseudogenes). By contrast, the human genome
has only the one pseudogene.
A neighbor-joining dendrogram of human LCN and
mouse MUP proteins is illustrated in Fig. 5; subfamilies
can be distinguished based on evolutionary divergence.
Note that all mouse MUPs are clustered into a subgroup
near the top of the dendrogram, whereas the human
LCNs are split into several different branches—due to
the high degree of divergence of LCN proteins. The
mouse Mup cluster divergence is most closely associated
with human LCN9 and PAEP (Fig. 5). Note that the evolutionarily oldest human LCN genes include ORM1,
ORM2, APOM, APOD, RBP4, and LCN8.
Functions of MUPs in mice
MUPs and chemical communication

Due to their influence on pheromones, MUPs appear to
be involved in regulating transmission of social signals—such as identity, territorial marking, and mate
choice [104–106]. Most pheromones are small volatile
molecules that influence aggression, mating, feeding,

Fig. 5 Dendrogram of human LCNs and mouse MUPs, combined.
Although the names listed are the official human gene symbols and
mouse Mup gene symbols, this dendrogram was based on the
alignment of proteins (listed in Tables 1 and 3) using multiple
sequence alignment by CLUSTALW (http://www.genome.jp/tools/
clustalw/). Note that the human LCN9 gene is evolutionarily closest
to the mouse Mup cluster in this dendrogram

and territorial behavior within the same species [103,
107]. Mice use pheromones as cues to regulate social
behaviors. Neurons that detect pheromones reside in at
least two separate organs within the nasal cavity: the
vomeronasal organ (VNO) and the main olfactory epithelium (MOE). Each pheromone molecule is thought
to activate a dedicated subset of these sensory neurons—similar to the manner in which odorants are received by dedicated subsets of mammalian olfactory
receptors. However, the identity of the responding neurons that regulate specific social behaviors remains
largely unknown.
Pheromones have a short half-life, which can be prolonged by binding to the characteristic barrel pocket, in
the MUP protein. In addition, gradual release of a pheromone from a MUP protein allows the half-life of these
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airborne odor signals to be extended, e.g., to be used as
mammalian scent marks [108, 109].
MUPs are also linked to reproductive success in
males [110] and to social behavior, by adjusting the animal’s odor profile in response to different stimuli. This
function underscores how social environment plays an
important role in MUP production in both male and female mice. For example, MUP synthesis is upregulated
in a male mouse housed with a female, but downregulated when a male mouse is housed with other males
only [111]. Perhaps related to this, MUPs can be predictive of the onset of aggressive and dispersal behavior
among male mice [103].
In addition to serving as pheromone carriers, MUPs
can function as pheromones themselves. They facilitate
chemical information exchange to convey specific information (e.g., gender, social and reproductive status) between animals [70]. Recent research has revealed that
MUPs also act as kairomones, causing a fear reaction in
response to predators [112]. For example, the rat kairomone that triggers defensive behavior in mice is encoded
by the Mup13 gene [112].
Members of the MUP family are known to be involved
in intraspecies interplay, especially male-male aggression
in mice [103]. Female mice are attracted to urine-borne
male pheromones. MUP20, for example, has been shown
to be rewarding and attractive to female mice. MUPs excreted by male mice can also influence reproductive behavior and promote female attraction [103, 113–115].
The molecular mechanism promoting spontaneous ovulation involves direct stimulation of VNO nerves by four
residues on the NH2-terminus of MUP proteins [116].
MUPs may also be involved in mediating individual recognition and inbreeding avoidance [117, 118].
MUPs and metabolism

MUPs also appear to be involved in energy metabolism—
actions reminiscent of the lipocalins that have been implicated clinically in lipid disorders and metabolic syndrome
caused by obesity and type-2 diabetes [119, 120]. For example, mouse MUP1 regulates systemic glucose metabolism by modulating the hepatic gluconeogenic and/or
lipogenic programs [121–123]. Caloric restriction dramatically reduces MUP1 expression in mouse liver [124, 125]
and appears to decrease MUP4 and MUP5 expression, as
well [124, 126].
Decreased hepatic MUP1 levels have been linked to
obesity and type-2 diabetes in mice with either genetic
(leptin receptor-deficient db/db) or dietary fat-induced
obesity [121, 127]. Similar decreases in MUP1 are found
in extrahepatic organs—such as adipose tissue and the
hypothalamus—after caloric restriction [128, 129]. Furthermore, MUP1 was also found to lower blood glucose
levels by inhibiting expression of phosphoenolpyruvate
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carboxykinase and glucose-6-phosphatase, two rate-limiting enzymes for gluconeogenesis [127]. These studies
suggest that mouse MUP1, and possibly other MUP
family members, are playing key roles in energy metabolism and potentially contributing to the development of
metabolic diseases such as type-2 diabetes.

Human LCN-like genes and their mouse orthologs
We have listed the human LCN-related genes in Table 1
and mouse Lcn-like genes plus the Mup cluster genes
in Table 3. What are the percent similarities of proteins—if one compares human LCN-like genes with
their mouse orthologs? Among the 19 LCN-like genes
in the human genome (Table 4), 17 have mouse orthologs, whereas human LCN1 and PAEP do not. Within
the LCN cluster, LCN6 and LCN8 exhibit the highest
percent similarity: 74 and 70%, respectively. Among all
19 LCN-like genes, RBP4 and APOM reveal the highest
percent similarity (86% and 81%, respectively); LCN15
and OBP2A display the lowest percent similarity (39%)
to their mouse orthologs.
Human and mouse ancestors are estimated to have diverged from one another ~ 80 million years ago. Table 4
confirms the relatively rapid rate of evolutionary divergence by the LCN-like genes, which is consistent with
Table 4 List of the 19 LCN-like genes in the human genome
and their similarity to their mouse orthologs, expressed as
percent identity (%)
Gene

Similarity to mouse
(percent identity (%))

LCN1

NA

LCN2

62

LCN6

74

LCN8

70

LCN9

54

LCN10

64

LCN12

56

LCN15

39

OBP2A

39

OBP2B

50

AMBP

77

APOD

74

APOM

81

C8G

76

ORM1

49

ORM2

44

PAEP

NA

PTGDS

72

RBP4

86
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their function of requiring evolutionarily quick adaptation
to changing environments; this is similar to, e.g., betadefensin (DEFB) genes, which number almost four dozen
in the human genome and encode broad-spectrum antimicrobial cationic peptides [130]. Out of 19 LCN-like
genes, the appearance of two novel human genes (LCN1
and PAEP) during the past ~ 80 million years is further
evidence of an enhanced evolutionary rate for this gene
superfamily.
Rapid rates of evolutionary divergence stand in sharp
contrast to, e.g., highly conserved transcription factors,
whose human-mouse orthologs are generally > 95%
similar in protein sequence. In fact, assaying for complementation of lethal growth defects in yeast, almost
half (47%) of the yeast genes could be successfully humanized [131], and the yeast-human divergence occurred well over one billion years ago.

Conclusions
Lipocalins (LCNs) are members of a family of evolutionarily conserved small proteins that possess a binding pocket. The LCN proteins (18–40 kDa) are encoded
by 19 human LCN-related genes and 45 mouse Lcn-related genes. LCN proteins are expressed in numerous
tissues and play important roles in physiological processes by transporting molecules in plasma and other
body fluids. In humans, LCNs are extensively used clinically as biochemical markers in various diseases—such
as diabetic renal disease, systemic lupus erythematosus,
and chronic inflammation.
In mice, major urinary proteins (MUPs) are also members of the lipocalin family. The Mup cluster of 22 functional protein-coding Mup genes (plus 29 of 30 Mup-ps
pseudogenes) is confined to mouse Chr 4 and represents
an “evolutionary bloom,” because only one or a few
MUP genes are functional in other mammals. In fact, no
functional MUP gene exists in the human genome—although a human MUPP pseudogene located at Chr 9q32
is syntenic to the Mup cluster on Chr 4.
The MUP protein structure contains a conserved “barrel” formed by the eight β-chains having the characteristic central hydrophobic pocket binding-site. Mouse
MUP proteins are expressed mainly in the liver, secreted
into the bloodstream, and excreted by the kidney. MUPs
are involved in the communication of information in
urine-derived scent marks and can also serve as pheromones themselves. Circulating MUPs may also contribute to regulation of nutrient metabolism—possibly by
suppressing hepatic gluconeogenic and lipid metabolism.
However, it still remains unclear how MUPs, especially
mouse MUP1, regulate energy metabolism and the gluconeogenic pathway. Further studies will be needed to
shed light on these mechanisms.
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